Skip to main content
Voyageur Pharmaceuticals Ltd. logo

Voyageur Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · VM ISIN · CA92918C1014 TSXV Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2024-12-24 Regulatory Filings
Country CA Canada
Listing TSXV VM

About Voyageur Pharmaceuticals Ltd.

https://voyageurpharmaceuticals.ca/

Voyageur Pharmaceuticals Ltd. develops and supplies contrast media products for medical imaging, including CT scans and fluoroscopy. The company operates using a vertically integrated "Earth to Bottle" strategy, controlling the entire supply chain from raw mineral acquisition to finished pharmaceutical product. Voyageur owns a significant, high-purity barium sulfate resource, positioning it as a secure and sustainable supplier of pharmaceutical-grade barium sulfate, the active ingredient in its commercialized contrast agents (e.g., SmoothX® and SmoothHD® series). This vertical control aims to ensure supply security and cost competitiveness, primarily targeting the North American market. The company is also actively developing iodine-based contrast media and V-Gas® Effervescent Granules to expand its portfolio of diagnostic imaging solutions.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings Classification · 90% confidence The document is a Canadian continuous-disclosure "Material Change Report" filed on Form 51-102F3, describing private placement closings and an LOI. This is a mandatory regulatory filing under NI 51-102, not an earnings release, investor presentation, call transcript or management discussion. It does not fit any more specific category, so it falls under the general Regulatory Filings category (RNS).
2024-12-24 English
News release - English.pdf
Regulatory Filings Classification · 82% confidence The document is a press release announcing a Letter of Intent (LOI) for a strategic collaboration. It is not a financial results release, dividend notice, management change, M&A transaction, or capital fundraising. It does not include an attached report or proxy materials, nor is it an earnings transcript. It functions as a general corporate announcement, so it falls into the fallback category for miscellaneous regulatory announcements: RNS.
2024-12-20 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a corporate news release announcing the closing of the final tranche of a non-brokered private placement, detailing the number of units issued, gross proceeds, use of funds, and related financing terms. This is a direct update on the company’s fundraising activity and capital structure. Therefore, it falls under Capital/Financing Update (CAP).
2024-12-19 English
Material change report - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a Canadian NI 51-102F3 Material Change Report detailing the closing of the first tranche of a non-brokered private placement, including units issued, broker warrants, and gross proceeds. This constitutes a fundraising/capital structure update rather than an annual report, audit, AGM material, or other category. It is therefore best classified as a Capital/Financing Update.
2024-12-13 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 45-106F1 “Report of Exempt Distribution,” which is a standardized Canadian regulatory filing detailing the distribution of securities under prospectus exemptions. It does not match any of the specialized categories for earnings releases, annual reports, management changes, or investor presentations. Therefore it falls into the fallback category for miscellaneous regulatory filings.
2024-12-13 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release announcing the closing of the first tranche of a non-brokered private placement, detailing the number of units issued, proceeds, use of proceeds, broker warrants, and regulatory conditions. This clearly constitutes a capital raising or financing activity. Therefore, it falls under the “Capital/Financing Update” category (CAP).
2024-12-04 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.